NCT05115097

Brief Summary

In this study the investigators record sounds of voice, breaths and cough of subjects who tested positive for COVID19. The investigators then feed these sounds into an artificial intelligence and see if it can learn to recognise features to make COVID19 diagnosis from these sounds in order to avoid to use swabs to test the general population.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 9, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 10, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

January 18, 2022

Status Verified

January 1, 2022

Enrollment Period

12 months

First QC Date

November 9, 2021

Last Update Submit

January 2, 2022

Conditions

Keywords

COVID-19artificial intelligencemachine learningsoundcoughbreathvoicediagnosisautomationAIMLpneumoniasymptomsairwaysSARS-CoV-2

Outcome Measures

Primary Outcomes (1)

  • Accuracy evaluation

    The investigators will evaluate the accuracy of the ML algorithm in terms of sensitivity and specificity and ROC-AUC

    September 2022-December 2022

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study participants from the general population meeting the inclusion criteria will be included in three cohorts: 1. SARS-CoV-2 positive 2. SARS-CoV-2 negative but with respiratory disease 3. Healthy volunteers

You may qualify if:

  • Adults who tested positive for SARS-CoV-2 currently admitted to hospital at the study site
  • Adults who tested negative for SARS-CoV-2 and are admitted for any respiratory condition (eg COPD or asthma flare-up, pneumonia..)
  • Healthy volunteers

You may not qualify if:

  • Patients under the age of 18.
  • Patients unable to read in Italian.
  • Patients unable to give informed consent to participate.
  • Patients requiring life support (including, but not limited to, mechanical cardiac support, ventilation, etc.)
  • Patients who are pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San Raffaele Hospital and Scientific Institute

Milan, (Mi), 20132, Italy

RECRUITING

MeSH Terms

Conditions

COVID-19CoughRespiratory SoundsMouth BreathingDiseasePneumonia

Condition Hierarchy (Ancestors)

Pneumonia, ViralRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • Marco Montagna, Medicine

    Vita-Salute San Raffaele University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marco Montagna, Medicine

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor, Head of Endocrino-Metabolic and Diabetologic Medicine

Study Record Dates

First Submitted

November 9, 2021

First Posted

November 10, 2021

Study Start

September 20, 2021

Primary Completion

September 1, 2022

Study Completion

December 1, 2022

Last Updated

January 18, 2022

Record last verified: 2022-01

Locations